FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385704477> ?p ?o ?g. }

• W4385704477 endingPage "2107" @default.
• W4385704477 startingPage "2107" @default.
• W4385704477 abstract "Amiodarone is underutilized due to significant off-target toxicities. We hypothesized that targeted delivery to the heart would lead to the lowering of the dose by utilizing a cardiomyocyte-targeting peptide (CTP), a cell-penetrating peptide identified by our prior phage display work.CTP was synthesized thiolated at the N-terminus, conjugated to amiodarone via Schiff base chemistry, HPLC purified, and confirmed with MALDI/TOF. The stability of the conjugate was assessed using serial HPLCs. Guinea pigs (GP) were injected intraperitoneally daily with vehicle (7 days), amiodarone (7 days; 80 mg/kg), CTP-amiodarone (5 days; 26.3 mg/kg), or CTP (5 days; 17.8 mg/kg), after which the GPs were euthanized, and the hearts were excised and perfused on a Langendorff apparatus with Tyrode's solution and blebbistatin (5 µM) to minimize the contractions. Voltage (RH237) and Ca2+-indicator dye (Rhod-2/AM) were injected, and fluorescence from the epicardium split and was captured by two cameras at 570-595 nm for the cytosolic Ca2+ and 610-750 nm wavelengths for the voltage. Subsequently, the hearts were paced at 250 ms with programmed stimulation to measure the changes in the conduction velocities (CV), action potential duration (APD), and Ca2+ transient durations at 90% recovery (CaTD90). mRNA was extracted from all hearts, and RNA sequencing was performed with results compared to the control hearts.The CTP-amiodarone remained stable for up to 21 days at 37 °C. At ~1/15th of the dose of amiodarone, the CTP-amiodarone decreased the CV in hearts significantly compared to the control GPs (0.92 ± 0.05 vs. 1.00 ± 0.03 ms, p = 0.0007), equivalent to amiodarone alone (0.87 ± 0.08 ms, p = 0.0003). Amiodarone increased the APD (192 ± 5 ms vs. 175 ± 8 ms for vehicle, p = 0.0025), while CTP-amiodarone decreased it significantly (157 ± 16 ms, p = 0.0136), similar to CTP alone (155 ± 13 ms, p = 0.0039). Both amiodarone and CTP-amiodarone significantly decreased the calcium transients compared to the controls. CTP-amiodarone and CTP decreased the CaTD90 to an extent greater than amiodarone alone (p < 0.001). RNA-seq showed that CTP alone increased the expression of DHPR and SERCA2a, while it decreased the expression of the proinflammatory genes, NF-kappa B, TNF-α, IL-1β, and IL-6.Our data suggest that CTP can deliver amiodarone to cardiomyocytes at ~1/15th the total molar dose of the amiodarone needed to produce a comparable slowing of CVs. The ability of CTP to decrease the AP durations and CaTD90 may be related to its increase in the expression of Ca-handling genes, which merits further study." @default.
• W4385704477 created "2023-08-10" @default.
• W4385704477 creator A5000101808 @default.
• W4385704477 creator A5015004592 @default.
• W4385704477 creator A5025283915 @default.
• W4385704477 creator A5043029873 @default.
• W4385704477 creator A5043874326 @default.
• W4385704477 creator A5055467154 @default.
• W4385704477 creator A5061933508 @default.
• W4385704477 creator A5072268661 @default.
• W4385704477 date "2023-08-09" @default.
• W4385704477 modified "2023-10-18" @default.
• W4385704477 title "Cardiomyocyte-Targeting Peptide to Deliver Amiodarone" @default.
• W4385704477 cites W1924098982 @default.
• W4385704477 cites W1978348074 @default.
• W4385704477 cites W1989383075 @default.
• W4385704477 cites W1993053689 @default.
• W4385704477 cites W1998162097 @default.
• W4385704477 cites W2015615249 @default.
• W4385704477 cites W2023453364 @default.
• W4385704477 cites W2031630601 @default.
• W4385704477 cites W2050392216 @default.
• W4385704477 cites W2066466450 @default.
• W4385704477 cites W2070050178 @default.
• W4385704477 cites W2076859770 @default.
• W4385704477 cites W2079335891 @default.
• W4385704477 cites W2084763417 @default.
• W4385704477 cites W2099292859 @default.
• W4385704477 cites W2105668301 @default.
• W4385704477 cites W2114104545 @default.
• W4385704477 cites W2118070181 @default.
• W4385704477 cites W2119818163 @default.
• W4385704477 cites W2128644325 @default.
• W4385704477 cites W2131271579 @default.
• W4385704477 cites W2134575216 @default.
• W4385704477 cites W2154267665 @default.
• W4385704477 cites W2158416204 @default.
• W4385704477 cites W2166887354 @default.
• W4385704477 cites W2197124664 @default.
• W4385704477 cites W2223680685 @default.
• W4385704477 cites W2290027246 @default.
• W4385704477 cites W2326579808 @default.
• W4385704477 cites W2402473637 @default.
• W4385704477 cites W2412399840 @default.
• W4385704477 cites W2425496252 @default.
• W4385704477 cites W2432815617 @default.
• W4385704477 cites W2605024653 @default.
• W4385704477 cites W2796973873 @default.
• W4385704477 cites W2800183969 @default.
• W4385704477 cites W2900974820 @default.
• W4385704477 cites W2910505719 @default.
• W4385704477 cites W2920804236 @default.
• W4385704477 cites W2940793653 @default.
• W4385704477 cites W2965766977 @default.
• W4385704477 cites W3012210512 @default.
• W4385704477 cites W3037538189 @default.
• W4385704477 cites W3107625280 @default.
• W4385704477 cites W3136569020 @default.
• W4385704477 cites W3164836190 @default.
• W4385704477 cites W3194283352 @default.
• W4385704477 cites W4220977210 @default.
• W4385704477 cites W4285733017 @default.
• W4385704477 cites W4313333744 @default.
• W4385704477 cites W4384024080 @default.
• W4385704477 cites W797967506 @default.
• W4385704477 doi "https://doi.org/10.3390/pharmaceutics15082107" @default.
• W4385704477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37631321" @default.
• W4385704477 hasPublicationYear "2023" @default.
• W4385704477 type Work @default.
• W4385704477 citedByCount "0" @default.
• W4385704477 crossrefType "journal-article" @default.
• W4385704477 hasAuthorship W4385704477A5000101808 @default.
• W4385704477 hasAuthorship W4385704477A5015004592 @default.
• W4385704477 hasAuthorship W4385704477A5025283915 @default.
• W4385704477 hasAuthorship W4385704477A5043029873 @default.
• W4385704477 hasAuthorship W4385704477A5043874326 @default.
• W4385704477 hasAuthorship W4385704477A5055467154 @default.
• W4385704477 hasAuthorship W4385704477A5061933508 @default.
• W4385704477 hasAuthorship W4385704477A5072268661 @default.
• W4385704477 hasBestOaLocation W43857044771 @default.
• W4385704477 hasConcept C126322002 @default.
• W4385704477 hasConcept C181199279 @default.
• W4385704477 hasConcept C185592680 @default.
• W4385704477 hasConcept C2778094803 @default.
• W4385704477 hasConcept C2779161974 @default.
• W4385704477 hasConcept C2779281246 @default.
• W4385704477 hasConcept C55493867 @default.
• W4385704477 hasConcept C71924100 @default.
• W4385704477 hasConcept C98274493 @default.
• W4385704477 hasConcept C98539663 @default.
• W4385704477 hasConceptScore W4385704477C126322002 @default.
• W4385704477 hasConceptScore W4385704477C181199279 @default.
• W4385704477 hasConceptScore W4385704477C185592680 @default.
• W4385704477 hasConceptScore W4385704477C2778094803 @default.
• W4385704477 hasConceptScore W4385704477C2779161974 @default.
• W4385704477 hasConceptScore W4385704477C2779281246 @default.
• W4385704477 hasConceptScore W4385704477C55493867 @default.
• W4385704477 hasConceptScore W4385704477C71924100 @default.

• next